Alnylam Competitors and Similar CompaniesClear all

Celyad's competitors and similar companies include Sorrento Therapeutics and Regulus Therapeutics.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Founding Date
Founding Date
2007
Founding Date
2006
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
San Diego, US HQ
San Diego, US
Locations
San Diego, US HQ
Employees
Employees
17
Employees
31019% decrease
Employees
2462% decrease
Valuation ($)
Valuation ($)
11.8 m
Valuation ($)
1.5 m
Valuation ($)
105.4 m

Financial

Revenue (est.)
Revenue (est.)
€102k (FY, 2023)
Revenue (est.)
$62.8m (FY, 2022)
Revenue (est.)
N/A
Net income
Net income
(€8.4m) (FY, 2023)
Net income
($577.8m) (FY, 2022)
Net income
($30m) (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 42.6m
Total funding raised
$ 10m
For sources of this data, please see the company profile

View Company Profiles

Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company